The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human phase 1 study of TQB6411, an EGFR/c-Met bispecific antibody-drug conjugate (ADC), in patients with advanced solid tumors.
 
Shengxiang Ren
No Relationships to Disclose
 
Feng Wang
No Relationships to Disclose
 
Jia Yu
No Relationships to Disclose
 
Qiyu Fang
No Relationships to Disclose
 
Lei Wang
No Relationships to Disclose
 
Xiangrui Meng
No Relationships to Disclose
 
Zhengzheng Shan
No Relationships to Disclose
 
Xiaozhen Liu
No Relationships to Disclose
 
Aiwu Li
No Relationships to Disclose
 
Tao Jiang
No Relationships to Disclose
 
Lingyun Ye
No Relationships to Disclose
 
Sha Zhao
No Relationships to Disclose
 
Yan Wang
No Relationships to Disclose
 
Juanjuan Li
No Relationships to Disclose
 
Dacheng Xie
No Relationships to Disclose
 
Xunqiang Wang
Employment - Chia Tai Tianqing Pharmaceutical Group
Stock and Other Ownership Interests - Chia Tai Tianqing Pharmaceutical Group
Honoraria - Chia Tai Tianqing Pharmaceutical Group
 
Ding Yu
Employment - Chia Tai Tianqing Pharmaceutical Group
Stock and Other Ownership Interests - Chia Tai Tianqing Pharmaceutical Group
Honoraria - Chia Tai Tianqing Pharmaceutical Group
 
Yafei Wang
Employment - Chia Tai Tianqing Pharmaceutical Group
Honoraria - Chia Tai Tianqing Pharmaceutical Group
 
Yong Tang
Employment - Chia Tai Tianqing Pharmaceutical Group
Honoraria - Chia Tai Tianqing Pharmaceutical Group